TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ORGO

Organogenesis Holdings Inc

Healthcare · Drug Manufacturers - Specialty & Generic

1.40$ -0.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Organogenesis Holdings Inc (ORGO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 406 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ORGO
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
463 460 458 443 446 498 467 461 510 599 520 406
226 225 227 234 239 286 268 260 300 362 269 200
98 104 89 90 94 136 110 73 64 94 92 46
98 104 89 90 94 136 110 73 64 94 92 46
89 82 96 106 101 110 103 120 169 217 117 101
28 28 28 27 27 26 29 33 40 30 28 29
29 29 29 29 29 29 29 29 29 29 29 29
17 16 15 14 13 12 12 11 9.9 9.1 3.4 3.0
186 181 180 180 168 113 99 100 124 165 139 118
81 81 83 86 77 77 65 66 90 100 76 57
22 20 22 20 18 9.1 9.3 9.8 9.8 19 9.7 9.3
27 31 23 29 24 29 25 30 40 32 29 29
62 61 59 58 56 – – – – – – –
277 279 278 264 279 385 368 361 386 434 381 288
-40 -41 -43 -60 -48 -40 -59 -68 -47 -3.1 -56 -153
133 132 132 133 134 132 126 127 131 132 128 129

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?